Company Spotlight

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile


Contract Service Directory


Rentschler Biopharma SE





Company Headquarters

Erwin-Rentschler-Str. 21
Laupheim, 88471
Germany

Company Description

Rentschler Biopharma, a leading contract development and manufacturing organization (CDMO), focuses exclusively on client projects. From its headquarters in Laupheim, Germany, and its site in Milford, MA, USA, the company offers process development and manufacturing of biopharmaceuticals as well as project management and regulatory support.

Contract Service Directory

    Related Content

    • Bio News | Breaking News | Industry News | Promotions & Moves
      Rentschler Biopharma Appoints New Executives to Join U.S. Team

      Rentschler Biopharma Appoints New Executives to Join U.S. Team

      New heads of Process Sciences and Human Resources departments.
      11.20.19

    • CDMOs to Benefit From Rising BTDs, Orphan Drugs and Fast Track Status

      CDMOs to Benefit From Rising BTDs, Orphan Drugs and Fast Track Status

      The arrival of patient-centric CDMO’s predicted by CPhI Annual Report.
      11.14.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Rentschler Kicks Off Expansion at U.S. Facility

      Rentschler Kicks Off Expansion at U.S. Facility

      New 500 L bioreactor in operation mid-2020 at U.S. site.
      11.11.19


    • Bio News | Breaking News | Industry News
      Nikolaus Rentschler and Frank Mathias are "EY Entrepreneur of the Year"

      Nikolaus Rentschler and Frank Mathias are "EY Entrepreneur of the Year"

      Rentschler Biopharma management duo received the award on October 25.
      11.01.19

    • cGMP Manufacture | Drug Development
      Contract Pharma’s 20th Anniversary Series: CDMO Insight

      Contract Pharma’s 20th Anniversary Series: CDMO Insight

      JoyL Silva of Pfizer CentreOne discusses global market and regulatory changes driving drug development strategies and the evolution of CDMO services and ops.
      Kristin Brooks, Contract Pharma 11.01.19

    • Regulatory Affairs | Serialization
      Fighting Back!

      Fighting Back!

      The drug industry takes a bare-knuckle approach to drug counterfeiters.
      Daniela Geiger, Vetter 10.04.19


    • Bio News | Breaking News | Collaborations & Alliances | Industry News
      Rentschler Expands Collaboration with Summit

      Rentschler Expands Collaboration with Summit

      New contracts secured with Japanese pharmaceutical companies
      10.04.19

    • Breaking News | Industry News | Regulatory Affairs
      LSNE

      LSNE's Spain Site Gets FDA Approval

      LSNE-León is the fourth facility to gain commercial approval
      10.04.19

    • Cytotoxics and High Potency Manufacturing
      Highly Potent Expansions

      Highly Potent Expansions

      CDMOs see HPAPI demand rising
      S. Harachand, Contributing Editor 09.16.19


    • Breaking News | Industry News | Solid Dosage/Creams/Ointments | Solid Dosage/Semi-solids
      Upperton Pharma Solutions Investment Increases Tabletting Capabilities

      Upperton Pharma Solutions Investment Increases Tabletting Capabilities

      New Futorque X tablet press is designed to support R&D studies and production batches
      09.16.19

    • cGMP Manufacture | Clinical Trial Materials | Industry News
      Rentschler Biopharma Takes on New Projects at Milford, MA Facility

      Rentschler Biopharma Takes on New Projects at Milford, MA Facility

      The site will support both clinical and commercial manufacturing programs
      09.04.19

    • Breaking News | Industry News | Inspections
      Bora Secures FDA Approval for CDMO Services

      Bora Secures FDA Approval for CDMO Services

      Reports successful inspection of Zhunan, Taiwan site
      09.03.19


    • Preparing for Your CDMO Selection Process

      Preparing for Your CDMO Selection Process

      Finding the CDMO that is right for your company and project can be a daunting task, particularly if this is your first time outsourcing.

    • APIs | Breaking News | Industry News
      Regis Technologies Expands Capabilities

      Regis Technologies Expands Capabilities

      CDMO now offering solid state chemistry services
      07.03.19

    • Breaking News | Fill/Finish | Industry News | Promotions & Moves
      Rentschler Fill Solutions Names Friedrich Sernetz as CEO

      Rentschler Fill Solutions Names Friedrich Sernetz as CEO

      Collaboration in operations strengthens strategic alliance between Rentschler Fill Solutions GmbH and Rentschler Biopharma SE
      06.10.19